![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.235 | -4.94% | 4.52 | 4.35 | 4.69 | 4.75 | 4.36 | 4.75 | 212,429 | 16:35:15 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.50 | 9.58M |
Date | Subject | Author | Discuss |
---|---|---|---|
22/8/2020 16:26 | That's the guild thread that I refer to ... | ![]() jjmills56 | |
22/8/2020 16:25 | Sorry I can too but it won't accept a reply post , does yours ? If so it's problem this end .... hence I reply via this thread ... | ![]() jjmills56 | |
22/8/2020 15:55 | jj I can see all threads on my mobile app just assumed everyone could. | 99bjd | |
22/8/2020 15:06 | We'll done re guild numbers and guild thread itself which is informative amusing at times and clean !.....it's just a pity it can't be accessed from the app via mobile.... does anyone know why this is so and how to overcome it ? | ![]() jjmills56 | |
22/8/2020 14:38 | Sorry I was out. You are all in now! | ![]() nobbygnome | |
22/8/2020 14:07 | Yes, I'm aware SNG is not just a covid company - that's why I mentioned COPD in my last post... and as for the risk - yes, that's why I'm keen to know whether the delivery of COPD results is still on-track... | ![]() sloppyjoe2 | |
22/8/2020 14:01 | The point is SNG is not a pure Covid company. It's entirely possible that COPD trials fail in which case they will become a covid dependent company. So still a lot of risk with the trials and could easy crash back down. | ![]() sikhthetech | |
22/8/2020 13:54 | and see the WHO info I postd the other day. COPD is a huge killer, worldwide, responsible for 5% of all global deaths (in 2016, think that was)... | ![]() sloppyjoe2 | |
22/8/2020 13:51 | SNG is trying to provide TREATMENT for Covid and COPD. It's not a vaccine. The point is people will need treating until everyone is vaccinated and there are millions who need it right now. SNG is also hoping similar TREATMENT can be use for asthma/COPD. That is where the long term future lies. According to this article there are 1.2m people suffering from COPD in UK alone and 115k new cases are diagnosed every year. COPD is also the 4th leading cause of death. That's without taking into account Covid. Globally, COPD is the fourth leading cause of death and expected to be the third by 2020. An estimated 1.2 million people are affected by COPD in the UK. There are 115,000 new diagnoses a year. Nevertheless, COPD remains underdiagnosed. 60-85% of patients, mainly with mild-to-moderate disease, are thought to remain undiagnosed. Most patients are not diagnosed until they are in their fifties. COPD is closely associated with levels of deprivation - rates of COPD are higher in more deprived communities. COPD is often associated with comorbidities, particularly cardiovascular disease, metabolic syndrome, lung cancer, osteoporosis, muscle weakness, depression and anxiety. | ![]() sikhthetech | |
22/8/2020 13:08 | Have we heard from the company lately to confirm that the COPD read-out is still on track for August? | ![]() sloppyjoe2 | |
22/8/2020 13:00 | Ah, hold on, I've logged off and back on again, and can now see the thread on my laptop. Excellent. Still not allowed on my iPad tho, boo. | ![]() teaboy100 | |
22/8/2020 12:58 | Nobby - thank you for the coin(s) - I think a join request has been sent, I'm guessing to you? | ![]() sloppyjoe2 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions